Journal article
Canadian consensus statement on the management of radioactive iodine–resistant differentiated thyroid cancer
Abstract
Radioactive iodine-resistant differentiated thyroid cancer (RAIRTC) is an aggressive form of thyroid cancer that is uncommon and heterogeneous in its clinical behavior. With the emergence of more effective systemic therapy, the need for guidance in decision-making was recognized and a consensus committee of national experts was assembled. The consensus committee consisted of 13 clinicians involved in treating RAIRTC from across Canada and …
Authors
Boucher A; Ezzat S; Hotte S; Rachinsky I; Rajaraman M; Ruether D; Wiseman SM; Brierley J; Ho C; Krzyzanowska M
Journal
Oral Oncology, Vol. 121, ,
Publisher
Elsevier
Publication Date
10 2021
DOI
10.1016/j.oraloncology.2021.105477
ISSN
1368-8375